Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Live webinar: Optimise your digital assets with UX research
- Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST
Research Partnership
- Rare diseases and orphan drugs: Our experience and expertise
Research Partnership
- Conducting research for publication video
Research Partnership
- Conference research case study
- How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
- Portfolio analysis: Using market research to master communications across a therapeutic category
Research Partnership
- EphMRA round up 2018
- EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership
- About us
- Contact us
- How to advertise
- Site map
- All content copyright © PMGroup Worldwide Ltd 2018
